End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,105 KRW | +9.86% | +5.30% | -44.02% |
Mar. 18 | Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel' | CI |
2022 | Shaperon Inc. has completed an IPO in the amount of KRW 13.735 billion. | CI |
Chart calendar Shaperon Inc.
Upcoming events on Shaperon Inc.
Past events on Shaperon Inc.
2024-06-02 | BIO International Convention |
2024-05-29 01:00 am | Investor Meeting |
2024-05-15 | Q1 2024 Earnings Release |
2023-11-13 | Q3 2023 Earnings Release |
2023-08-13 | Q2 2023 Earnings Release |
2023-05-14 | Q1 2023 Earnings Release |
2023-03-20 | Q4 2022 Earnings Release |
Past sector events for Shaperon Inc.
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- A378800 Stock
- Calendar Shaperon Inc.